{"id":"4d312fcb-4a8e-42d2-b649-3e0b54774770","slug":"leo-petrossian","name":"Leo Petrossian","bioBrief":"CEO of Neurolutions, a medical device company commercializing the IpsiHand Upper Extremity Rehabilitation System, the first FDA-authorized brain-computer interface device for chronic stroke rehabilitation (De Novo market authorization granted April 2021). He led the company's commercialization of the BCI-based handpiece, which translates brain signals from the uninjured hemisphere into movement of an impaired hand.","priorExits":null,"nationality":"American","verificationPosture":"reported","aliases":[],"sources":[{"url":"https://www.neurolutions.com/news/neurolutions-receives-fda-de-novo-market-authorization-for-ipsihand/","title":"NeuroLutions Receives FDA De Novo Market Authorization for IpsiHand","sourceName":"NeuroLutions"},{"url":"https://www.globenewswire.com/news-release/2021/04/26/2216682/0/en/Neurolutions-Receives-U-S-Food-and-Drug-Administration-De-Novo-Market-Authorization-for-IpsiHand-Upper-Extremity-Rehabilitation-System.html","title":"NeuroLutions Receives U.S. FDA De Novo Market Authorization for IpsiHand Upper Extremity Rehabilitation System","sourceName":"GlobeNewswire"}],"reviewStatus":"reviewed","createdAt":"2026-08-08T22:38:18.428Z","updatedAt":"2026-08-09T21:31:50.581Z","educations":[],"companyRoles":[{"id":"79a8ea47-1803-4290-984f-07810312350d","personId":"4d312fcb-4a8e-42d2-b649-3e0b54774770","companyId":"c5677c1a-8c95-438d-9619-849950504010","role":"ceo","roleTitle":"CEO","startDate":null,"endDate":null,"currentRole":true,"roleBasis":"verified_secondary","displayOrder":null,"createdAt":"2026-08-08T22:38:19.216Z","company":{"slug":"neurolutions","name":"NeuroLutions"}}],"boardRoles":[],"investorRoles":[],"foundings":[]}